99 related articles for article (PubMed ID: 233106)
1. [Cyclic nucleotide metabolism in the blood platelets and its relationship to the vascular wall].
Yamazaki H
Rinsho Byori; 1979; Suppl 40():40-6. PubMed ID: 233106
[No Abstract] [Full Text] [Related]
2. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
Hidaka H; Endo T
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
[No Abstract] [Full Text] [Related]
3. Cyclic nucleotide phosphodiesterases.
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():1-416. PubMed ID: 6326516
[No Abstract] [Full Text] [Related]
4. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
5. Drosophila cyclic nucleotide phosphodiesterases.
Davis RL; Kauvar LM
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
[No Abstract] [Full Text] [Related]
6. [Phosphodiesterases of cyclic GMP].
Wróblewska H; Gorczyca WA
Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
[TBL] [Abstract][Full Text] [Related]
7. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
8. Identification and properties of cyclic nucleotide phosphodiesterases.
Beavo JA; Hansen RS; Harrison SA; Hurwitz RL; Martins TJ; Mumby MC
Mol Cell Endocrinol; 1982; 28(3):387-410. PubMed ID: 6185373
[No Abstract] [Full Text] [Related]
9. Platelet aggregation and cyclic nucleotide phosphodiesterase activity in arteriosclerotic patients.
Yamazaki H; Motomiya T; Mashimo N; Asano T; Hidaka H
Thromb Haemost; 1978 Feb; 39(1):158-66. PubMed ID: 205971
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
11. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
Strada SJ; Martin MW; Thompson WJ
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
[No Abstract] [Full Text] [Related]
12. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
Davis CW; Daly JW
Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
[No Abstract] [Full Text] [Related]
13. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts.
Epstein PM; Hachisu R
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():303-24. PubMed ID: 6202124
[No Abstract] [Full Text] [Related]
14. Regulation of cyclic nucleotide phosphodiesterase activity.
Vaughan M; Danello MA; Manganiello VC; Strewler GJ
Adv Cyclic Nucleotide Res; 1981; 14():263-71. PubMed ID: 6169258
[No Abstract] [Full Text] [Related]
15. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
[No Abstract] [Full Text] [Related]
16. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
[No Abstract] [Full Text] [Related]
17. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
Hoskins B; Luong HB
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
[TBL] [Abstract][Full Text] [Related]
18. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain.
Singh R; Shankar R
Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810
[No Abstract] [Full Text] [Related]
19. Genetic analysis of cyclic nucleotide phosphodiesterases in Drosophila melanogaster.
Kiger JA; Davis RL; Salz H; Fletcher T; Bowling M
Adv Cyclic Nucleotide Res; 1981; 14():273-88. PubMed ID: 6269382
[No Abstract] [Full Text] [Related]
20. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
